Scpharmaceuticals Inc Financial Flexibility Index
Scpharmaceuticals Inc financial flexibility index. Scpharmaceuticals Inc (SCPH) has a Financial Flexibility Index of -0.16x as of June 2025. Free cash flow of $-16.11 Million (operating CF $-16.11 Million minus capex $0.00) represents 0% of total liabilities ($101.57 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Scpharmaceuticals Inc (2015–2024)
Financial flexibility index of Scpharmaceuticals Inc from 2015 to 2024. Historical Financial Flexibility Index trend for Scpharmaceuticals Inc across 10 annual periods. Explore Scpharmaceuticals Inc (SCPH) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Scpharmaceuticals Inc Financial Flexibility Index by Year (2015–2024)
Scpharmaceuticals Inc financial flexibility index by year from 2015 to 2024. Year-by-year free cash flow to debt coverage for Scpharmaceuticals Inc. For the full cash flow conversion analysis, see SCPH cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.75x | $-70.52 Million | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.20 Million | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.56 Million | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.14 Million | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.68 Million | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.43 Million | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.80 Million | $-28.81 Million | $15.01 Million | ▼ -37.0% |
| 2017 | -1.40x | $-22.49 Million | $-22.68 Million | $16.05 Million | ▼ -597.0% |
| 2016 | -0.20x | $-15.45 Million | $-15.46 Million | $76.85 Million | ▲ +58.0% |
| 2015 | -0.48x | $-9.62 Million | $-9.64 Million | $20.09 Million | — |